There are 2789 resources available
1407P - Patterns of aggravation in gastric cancer patients with peritoneal metastases who underwent paclitaxel-based intraperitoneal therapy
Presenter: Yasushi Tsuji
Session: ePoster Display
1408P - Efficacy of immunotherapy in the first line treatment of advanced upper gastrointestinal tract malignancies: A pooled analysis of randomized clinical trials
Presenter: Panagiotis Ntellas
Session: ePoster Display
1409P - Cost-effectiveness of pembrolizumab plus platinum and fluoropyrimidine-based chemotherapy as first-line treatment of advanced esophageal cancer in the United States
Presenter: Tingting Qu
Session: ePoster Display
1410P - Gastric cancer: Data from the AGAMENON-SEOM study
Presenter: Ismael Macias Declara
Session: ePoster Display
1312P - Prognostic impact of KRAS status in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitor monotherapy
Presenter: Giacomo Pelizzari
Session: ePoster Display
1314P - Preliminary results of sequential combination of immunotherapy followed by chemotherapy in advanced non-small cell lung cancer
Presenter: Luc Heraudet
Session: ePoster Display
1315P - Impact of high fasting plasma glucose in the clinical outcome of patients with advanced NSCLC with PD-L1 ≥ 50% treated with frontline pembrolizumab
Presenter: Sandra Llop Serna
Session: ePoster Display
1317P - Renal toxicity in black patients with non-squamous non-small cell lung cancer treated with combination platinum-pemetrexed-pembrolizumab therapy
Presenter: Nino Balanchivadze
Session: ePoster Display